1. FRI0244 Clinical efficacy of 2 dosing regimens of tru-015, a b cell-depleting agent, in subjects with active seropositive rheumatoid arthritis compared with placebo on a stable background of methotrexate. (23rd January 2014) Authors: Brodsky, A.; Diri, E.; Garcia-DeLaTorre, I.; Alvarez, D. F.; Bencan, C.; Bukowski, J.; Zang, C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗